Custom-engineered hydrogels for delivery of human iPSC-derived neurons into the injured cervical spinal cord

Biomaterials. 2024 Mar:305:122400. doi: 10.1016/j.biomaterials.2023.122400. Epub 2023 Nov 17.

Abstract

Cervical damage is the most prevalent type of spinal cord injury clinically, although few preclinical research studies focus on this anatomical region of injury. Here we present a combinatorial therapy composed of a custom-engineered, injectable hydrogel and human induced pluripotent stem cell (iPSC)-derived deep cortical neurons. The biomimetic hydrogel has a modular design that includes a protein-engineered component to allow customization of the cell-adhesive peptide sequence and a synthetic polymer component to allow customization of the gel mechanical properties. In vitro studies with encapsulated iPSC-neurons were used to select a bespoke hydrogel formulation that maintains cell viability and promotes neurite extension. Following injection into the injured cervical spinal cord in a rat contusion model, the hydrogel biodegraded over six weeks without causing any adverse reaction. Compared to cell delivery using saline, the hydrogel significantly improved the reproducibility of cell transplantation and integration into the host tissue. Across three metrics of animal behavior, this combinatorial therapy significantly improved sensorimotor function by six weeks post transplantation. Taken together, these findings demonstrate that design of a combinatorial therapy that includes a gel customized for a specific fate-restricted cell type can induce regeneration in the injured cervical spinal cord.

Keywords: Biomaterials; Cell transplantation; Hydrogel; Induced pluripotent stem cell; Spinal cord injury.

MeSH terms

  • Animals
  • Cervical Cord*
  • Humans
  • Hydrogels / chemistry
  • Induced Pluripotent Stem Cells*
  • Neurons
  • Rats
  • Reproducibility of Results
  • Spinal Cord
  • Spinal Cord Injuries*

Substances

  • Hydrogels